Report Detail
Global Oral Cholera Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4537688 |
- 30 June, 2023 |
- Global |
- 98 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Oral Cholera Vaccine market size was valued at USD 87 million in 2022 and is forecast to a readjusted size of USD 141.7 million by 2029 with a CAGR of 7.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
This report is a detailed and comprehensive analysis for global Oral Cholera Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oral Cholera Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Cholera Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Cholera Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Cholera Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Cholera Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Cholera Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PaxVax, Sanofi, Valneva, EuBiologics and United Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oral Cholera Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Market segment by Application
Preventive Campaigns
Outbreak Response
Major players covered
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Cholera Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Cholera Vaccine, with price, sales, revenue and global market share of Oral Cholera Vaccine from 2018 to 2023.
Chapter 3, the Oral Cholera Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Cholera Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Cholera Vaccine.
Chapter 14 and 15, to describe Oral Cholera Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Oral Cholera Vaccine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oral Cholera Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Euvichol-Plus
- 1.3.3 DUKORAL
- 1.3.4 Shanchol
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oral Cholera Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Preventive Campaigns
- 1.4.3 Outbreak Response
- 1.5 Global Oral Cholera Vaccine Market Size & Forecast
- 1.5.1 Global Oral Cholera Vaccine Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Oral Cholera Vaccine Sales Quantity (2018-2029)
- 1.5.3 Global Oral Cholera Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 PaxVax
- 2.1.1 PaxVax Details
- 2.1.2 PaxVax Major Business
- 2.1.3 PaxVax Oral Cholera Vaccine Product and Services
- 2.1.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 PaxVax Recent Developments/Updates
- 2.2 Sanofi
- 2.2.1 Sanofi Details
- 2.2.2 Sanofi Major Business
- 2.2.3 Sanofi Oral Cholera Vaccine Product and Services
- 2.2.4 Sanofi Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Sanofi Recent Developments/Updates
- 2.3 Valneva
- 2.3.1 Valneva Details
- 2.3.2 Valneva Major Business
- 2.3.3 Valneva Oral Cholera Vaccine Product and Services
- 2.3.4 Valneva Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Valneva Recent Developments/Updates
- 2.4 EuBiologics
- 2.4.1 EuBiologics Details
- 2.4.2 EuBiologics Major Business
- 2.4.3 EuBiologics Oral Cholera Vaccine Product and Services
- 2.4.4 EuBiologics Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 EuBiologics Recent Developments/Updates
- 2.5 United Biotech
- 2.5.1 United Biotech Details
- 2.5.2 United Biotech Major Business
- 2.5.3 United Biotech Oral Cholera Vaccine Product and Services
- 2.5.4 United Biotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 United Biotech Recent Developments/Updates
- 2.6 Vabiotech
- 2.6.1 Vabiotech Details
- 2.6.2 Vabiotech Major Business
- 2.6.3 Vabiotech Oral Cholera Vaccine Product and Services
- 2.6.4 Vabiotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Vabiotech Recent Developments/Updates
- 2.7 PaxVax
- 2.7.1 PaxVax Details
- 2.7.2 PaxVax Major Business
- 2.7.3 PaxVax Oral Cholera Vaccine Product and Services
- 2.7.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 PaxVax Recent Developments/Updates
3 Competitive Environment: Oral Cholera Vaccine by Manufacturer
- 3.1 Global Oral Cholera Vaccine Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Oral Cholera Vaccine Revenue by Manufacturer (2018-2023)
- 3.3 Global Oral Cholera Vaccine Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Oral Cholera Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Oral Cholera Vaccine Manufacturer Market Share in 2022
- 3.4.2 Top 6 Oral Cholera Vaccine Manufacturer Market Share in 2022
- 3.5 Oral Cholera Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Oral Cholera Vaccine Market: Region Footprint
- 3.5.2 Oral Cholera Vaccine Market: Company Product Type Footprint
- 3.5.3 Oral Cholera Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Oral Cholera Vaccine Market Size by Region
- 4.1.1 Global Oral Cholera Vaccine Sales Quantity by Region (2018-2029)
- 4.1.2 Global Oral Cholera Vaccine Consumption Value by Region (2018-2029)
- 4.1.3 Global Oral Cholera Vaccine Average Price by Region (2018-2029)
- 4.2 North America Oral Cholera Vaccine Consumption Value (2018-2029)
- 4.3 Europe Oral Cholera Vaccine Consumption Value (2018-2029)
- 4.4 Asia-Pacific Oral Cholera Vaccine Consumption Value (2018-2029)
- 4.5 South America Oral Cholera Vaccine Consumption Value (2018-2029)
- 4.6 Middle East and Africa Oral Cholera Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 5.2 Global Oral Cholera Vaccine Consumption Value by Type (2018-2029)
- 5.3 Global Oral Cholera Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 6.2 Global Oral Cholera Vaccine Consumption Value by Application (2018-2029)
- 6.3 Global Oral Cholera Vaccine Average Price by Application (2018-2029)
7 North America
- 7.1 North America Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 7.2 North America Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 7.3 North America Oral Cholera Vaccine Market Size by Country
- 7.3.1 North America Oral Cholera Vaccine Sales Quantity by Country (2018-2029)
- 7.3.2 North America Oral Cholera Vaccine Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 8.2 Europe Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 8.3 Europe Oral Cholera Vaccine Market Size by Country
- 8.3.1 Europe Oral Cholera Vaccine Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Oral Cholera Vaccine Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Oral Cholera Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 10.2 South America Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 10.3 South America Oral Cholera Vaccine Market Size by Country
- 10.3.1 South America Oral Cholera Vaccine Sales Quantity by Country (2018-2029)
- 10.3.2 South America Oral Cholera Vaccine Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Oral Cholera Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Oral Cholera Vaccine Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Oral Cholera Vaccine Market Drivers
- 12.2 Oral Cholera Vaccine Market Restraints
- 12.3 Oral Cholera Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Oral Cholera Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Oral Cholera Vaccine
- 13.3 Oral Cholera Vaccine Production Process
- 13.4 Oral Cholera Vaccine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Oral Cholera Vaccine Typical Distributors
- 14.3 Oral Cholera Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oral Cholera Vaccine. Industry analysis & Market Report on Oral Cholera Vaccine is a syndicated market report, published as Global Oral Cholera Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Oral Cholera Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
